Description     Claims  

WO2007145863A   [0002] 
US7375111B   [0008]  [0041]  [0053] 
US7462626B   [0008]  [0041]  [0053] 
US20070275970A   [0041] 
US20070270450A   [0041] 
US20070117827A   [0041] 
US20070179168A   [0041] 
US20080214592A   [0041] 
US20070128298A   [0041] 
US20070129283A   [0041] 
US751970   [0041] 
US61167486B   [0041] 
US61293844B   [0041] 
WO2009158114A   [0041] 
US20080113026A   [0048]  [0063] 
US20070281021A   [0053] 
US20080110792A   [0063] 

Annals of Medicine   [0003] 
Drugs R&D   [0004] 
Physical status: The use and interpretation of anthropometry   [0005] 
NHLBI Clinical Guidelines   [0006] 
disclose the combination of naltrexone and bupropion as an adjunct to an intensive behavioral modification (BMOD) program for weight loss   [0008] 
Remington's Pharmaceutical Sciences   [0053]